2022
DOI: 10.1186/s13568-022-01425-7
|View full text |Cite
|
Sign up to set email alerts
|

Genetic diversity of drug-resistant Mycobacterium tuberculosis clinical isolates from Khuzestan province, Iran

Abstract: The emergence of drug-resistant strains of the Mycobacterium tuberculosis (MTB) has challenged tuberculosis control programs. So far, few studies using the 24-locus mycobacterial interspersed repetitive unit variable number tandem repeats (MIRU-VNTR) have investigated the genetic diversity of MTB in Iran. This study aimed to determine the genetic diversity of MTB isolates resistant to first-line anti-tuberculosis drugs using 24-locus MIRU-VNTR in southwestern Iran. Out of 6620 MTB clinical isolates, 29 resista… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 40 publications
0
5
0
Order By: Relevance
“…Also, in comparison with conventional molecular phenotypic methods, it is the most stable and reliable (Kone et al 2020 ). One of the disadvantages of this method is that it is not suitable for isolates with low copy numbers (Bakhtiyariniya et al 2022 ). In spite of this, semi-automated RFLP has been found to be a robust and promising method for routinely typing MTB (Said et al 2016 ).…”
Section: Assays and Methodsmentioning
confidence: 99%
“…Also, in comparison with conventional molecular phenotypic methods, it is the most stable and reliable (Kone et al 2020 ). One of the disadvantages of this method is that it is not suitable for isolates with low copy numbers (Bakhtiyariniya et al 2022 ). In spite of this, semi-automated RFLP has been found to be a robust and promising method for routinely typing MTB (Said et al 2016 ).…”
Section: Assays and Methodsmentioning
confidence: 99%
“…The integration of tandem gene repeats via a bacterial type-II toxin-antitoxin-mediated gene amplification (ToxAmp) system and stability visualisation in Saccharomyces cerevisiae Samuel Evans 1,2 , Zeyu Lu 1,2,3 , Liam McDonnell 1,2 , Will Anderson 3 , Francisco Peralta 1,2 , Tyson Watkins 1,2 , Hafna Ahmed 4 , Carlos Horacio Luna-Flores 2 , Thomas Loan 5 , Laura Navone 2,6 , Matt Trau 3,7 , Colin Scott 4 , Robert Speight 1,2,8 , Claudia E. Vickers 1,2 , Bingyin Peng 1,2,3 * Introduction Tandem gene repeats, in the form of an array of two or more copies of a gene, commonly exist in cell genomes, i.e., ribosomal RNA genes (rDNA), 1 oncogenic genes, 2 drug resistant genes, 3,4 secondary metabolite biosynthetic genes, 5,6 and many other trait genes. 7 Their occurrence is generally regarded as the result of gene amplification, which increases gene copy number (gene dosage) and provides a phenotypic advantage during natural or artificial selection.…”
Section: For Table Of Contents Use Onlymentioning
confidence: 99%
“…The integration of tandem gene repeats via a bacterial type-II toxin-antitoxin-mediated gene amplification (ToxAmp) system and stability visualisation in Saccharomyces cerevisiae Samuel Evans 1,2 , Zeyu Lu 1,2,3 , Liam McDonnell 1,2 , Will Anderson 3 , Francisco Peralta 1,2 , Tyson Watkins 1,2 , Hafna Ahmed 4 , Carlos Horacio Luna-Flores 2 , Thomas Loan 5 , Laura Navone 2,6 , Matt Trau 3,7 , Colin Scott 4 , Robert Speight 1,2,8 , Claudia E. Vickers 1,2 , Bingyin Peng…”
Section: For Table Of Contents Use Onlymentioning
confidence: 99%
See 1 more Smart Citation
“…Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), continues to pose a significant global public health challenge. [1][2][3] In 2021, there were 10.6 million new TB cases worldwide, with China accounting for 780,000 cases, making it the third highest burden country for TB globally. 4 The World Health Organization (WHO) estimates that in 2021, there were 450,000 cases of rifampicin-resistant tuberculosis (RR-TB) globally, of which over 70% were multidrug-resistant tuberculosis (MDR-TB), characterized by resistance to both isoniazid and rifampicin simultaneously.…”
Section: Introductionmentioning
confidence: 99%